Find Academic Supervisors

Anirban PaulView profile

Associate Professor

• Neuroscience
• GABAergic inhibitory circuits
• Interneuron biology
• +5 more

Anirban Paul is an Associate Professor in the Department of Neuroscience and Experimental Therapeutics at Pennsylvania State University, affiliated with the Penn State Neuroscience Institute. His research focuses on cellular and molecular mechanisms of GABAergic inhibitory circuits, with particular emphasis on interneuron biology and its implications in neurological disorders. Dr. Paul's research spans multiple neuroscience domains, with primary focus on GABAergic inhibitory circuits and interneuron biology. His work investigates how specific neuron subtypes, particularly Chandelier cells and cortical interneurons, contribute to brain function and dysfunction. He has made significant contributions to understanding the role of these cells in schizophrenia, Alzheimer's disease, and other neurological conditions. His research integrates molecular, cellular, and systems-level approaches to uncover fundamental mechanisms of neural circuit assembly, plasticity, and function. Key areas include RNA regulation in neuronal development, transcriptomic subtypes of inhibitory neurons, and cell-type specific vulnerabilities in neurodegenerative diseases. His research portfolio demonstrates consistent productivity with publications spanning from 2003 to 2025, showing an evolving focus from basic molecular neuroscience to translational research in neurological disorders. Recent work emphasizes single-cell analysis techniques and the role of specific interneuron populations in disease mechanisms, particularly in schizophrenia and Alzheimer's disease. His publications appear in high-impact neuroscience journals including Neuron, BMC Biology, and Frontiers in Cellular Neuroscience. Dr. Paul has received the NARSAD Young Investigator Award (2018), recognizing his promising research in neuroscience. His scientific contributions have been supported by multiple competitive grants from prestigious organizations including the National Institute on Aging (NIA) and the Brain and Behavior Research Foundation. He serves as Principal Investigator on multiple active research projects, including two major grants from the National Institute on Aging focused on cell-type specific risk and resilience in Alzheimer's disease and aging (2021-2024 and 2024-2026), as well as previous projects from the Brain and Behavior Research Foundation investigating Chandelier cells in schizophrenia. His research program demonstrates sustained funding and scientific leadership in the field of interneuron biology and its clinical implications.

Jonny KohlView profile

Researcher

• Neuroscience
• Neural Circuits
• Behavioral Biology
• +4 more

Jonny Kohl is a Group Leader at the Francis Crick Institute , where he established the State-dependent Neural Processing Laboratory in 2019. His work bridges neural circuits and internal physiological states (e.g., hunger, pregnancy) to decode instinctive behaviors like parenting and aggression in mice. PhD: MRC Laboratory of Molecular Biology, Cambridge (2013) Postdoc: Harvard University (2014–2019) with support from EMBO, HFSP, and Wellcome Trust fellowships Research Interests : Kohl investigates how hormonal and metabolic states dynamically rewire neural circuits to drive adaptive behaviors. His lab combines circuit neuroscience , molecular biology , and behavioral profiling to study: State-dependent neural processing in parental behavior Chemosensory dominance hierarchies in mice Plasticity mechanisms in aggression circuits Development of ultrafast tissue labeling and cryoanesthesia tools Scientific Trends : His recent publications highlight hormone-mediated synaptic remodeling (2023), cost-effective lab tools (2023), and brain-wide activity mapping (2016). Collaborative work spans computational biology , metabolism , and imaging disciplines. Honors: NARSAD Young Investigator Award (2019), ERC Starting Grant (2019), Wellcome Trust Discovery Award (2025) Grants: BBSRC Research Grant (2025), BBSRC Pioneer Grant (2023) His lab mentors PhD and MSc students and has developed open-source neuroscience tools (e.g., cryoanesthesia device, 2023). Kohl's research has been featured in Nature , Science , and Cell .

Eduardo E. BenarrochView profile

Professor

• Neurodegenerative disorders
• Autonomic disorders
• Parkinson's disease
• +3 more

Eduardo E. Benarroch, M.D., is a Professor of Neurology and Consultant in the Department of Neurology at Mayo Clinic in Rochester, Minnesota. His research focuses on neurochemical mechanisms underlying neurodegenerative disorders such as multiple system atrophy (MSA) and Lewy body diseases, with emphasis on brainstem and hypothalamic neuronal groups controlling homeostasis. His work is supported by the MSA Coalition and has contributed to understanding autonomic, respiratory, and sleep symptom mechanisms in Parkinson's disease. Dr. Benarroch holds a D.Sci. in Physiology from Buenos Aires University and completed multiple fellowships including NIH Fogarty International Fellowship at Cornell University. He has held leadership roles including President of the American Autonomic Society and Co-Director of Mayo's Neuroscience Laboratory. His 286+ publications span neurochemical pathology, autonomic disorders, and clinical neurology. Awarded the AB Baker Lifetime Achievement Award in Neurologic Education, he has received repeated teaching honors including Mayo's Distinguished Educator Award. His professional memberships include American Academy of Neurology, Society for Neuroscience, and Sigma Xi. He has advised numerous trainees and contributed to consensus guidelines on dysphagia in neurodegenerative diseases.

Brandon WeissbourdView profile

Assistant Professor

• Neuroscience
• Evolutionary Biology
• Systems Neuroscience
• +3 more

Brandon Weissbourd is an Assistant Professor in the Biology department at the Massachusetts Institute of Technology (MIT) and holds a joint appointment as an Investigator at the Picower Institute for Learning and Memory. He joined MIT in 2023 after completing a postdoctoral fellowship in the lab of David Anderson at the California Institute of Technology (Caltech). Prior to that, he earned his PhD in Biology from Stanford University in 2016 under the mentorship of Liqun Luo, and a BA in Human Evolutionary Biology from Harvard University in 2009. His research interests encompass systems neuroscience, evolutionary biology, and molecular biology. He uses jellyfish models, such as Clytia hemisphaerica, to study the evolution and functional mechanisms of nervous systems. His work combines computational techniques like single-cell RNA-seq and advanced microscopy with traditional genetic and anatomical approaches to dissect neural circuits and their roles in behaviors like feeding and social interaction. Additionally, he has explored serotonin and noradrenaline systems in mammals, focusing on their heterogeneity and functional connectivity. Recent publications emphasize the utility of non-traditional model organisms for evolutionary studies and underscore his expertise in computational methods for neurobiological analysis. Earlier work includes groundbreaking studies on the dorsal raphe serotonin system and basal forebrain circuits governing sleep-wake cycles. No scientific awards or honors have been explicitly mentioned in the provided text. Weissbourd’s academic trajectory reflects a strong emphasis on interdisciplinary research, merging evolutionary, molecular, and systems-level perspectives to understand neural systems across species. His advising record is not detailed here, though he has been affiliated with prestigious research labs during his training. Current affiliations include the MIT Biology department and the Picower Institute, where he likely contributes to collaborative projects in systems and evolutionary neuroscience. Weissbourd’s work is grounded in experimental models such as Clytia medusa and mouse brain studies, enabling him to investigate both ancient nervous system architectures and modern mammalian neural pathways. His lab’s focus on functional genomics and circuit mapping positions him at the forefront of studies on neural diversity and evolutionary innovation.

• Obesity
• Energy balance
• Leptin signaling
• +5 more

Maia Kokoeva, PhD, is a Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) and an Associate Professor in the Department of Medicine, Division of Endocrinology, at McGill University’s Faculty of Medicine and Health Sciences. She leads studies on obesity and neuroendocrine control of energy balance, focusing on leptin sensing and the role of NG2-glia in the hypothalamus. Research Interests: Neuroendocrine regulation of body weight Leptin signaling and sensing mechanisms Hypothalamic circuits controlling energy expenditure NG2-glia biology and adult neurogenesis Genetic mouse models of obesity and diabetes Her recent publications illuminate how NG2-glia in the median eminence mediate leptin entry into the hypothalamus, uncovering new cellular players that could be targeted to prevent age-related weight gain. Laboratory and Affiliations: Dr Kokoeva heads a laboratory within the Metabolic Disorders and Complications Program of the Centre for Translational Biology at RI-MUHC, leveraging state-of-the-art imaging and genetic tools to dissect hypothalamic control of metabolism.

• Neuroscience
• Metabolism
• Behavioral Neuroscience
• +3 more

Dr. Paulius Viskaitis is a Researcher affiliated with the Rehabilitation Engineering Lab at ETH Zürich's Department of Health Sciences and Technology. His work focuses on the neurophysiological mechanisms underlying metabolic regulation, motor behavior, and neurological disorders. Key research areas include orexin neuron dynamics, hypothalamic circuitry, and their roles in movement, energy homeostasis, and epilepsy mitigation. His studies integrate experimental neuroscience with engineering approaches, exploring how neural networks encode metabolic states and behavioral outputs. Notable contributions include identifying orexin neurons' roles in blood glucose tracking and seizure suppression. Current research emphasizes translational applications in rehabilitation engineering and neurotherapeutic strategies. Dr. Viskaitis collaborates across disciplines, leveraging mouse models to investigate neural circuits governing feeding, locomotion, and decision-making. His findings bridge basic neuroscience with clinical applications, particularly in metabolic and motor disorders.

Almira VazdarjanovaView profile

Professor

• Neuroscience
• Neuropharmacology
• Behavioral Neuroscience
• +7 more

Almira Vazdarjanova is a Professor at the Medical College of Georgia, Augusta University, with academic appointments in the Department of Pharmacology and Toxicology and the Department of Neurology. Her work bridges neuroscience, pharmacology, and behavioral research, focusing on translational models of stress, memory, and feeding behavior. Education: Ph.D. in Biological and Biomedical Sciences, University of California - Irvine, 2000 M.S. in Biology/Biological Sciences, University of California - Irvine, 2000 B.S. in Biology/Biological Sciences, University of California - Irvine, 1995 Her research interests include neuropharmacology, behavioral neuroscience, sex differences in anxiety and fear, PTSD modeling, memory mechanisms, and hypothalamic regulation of feeding . She uses rodent and primate models to explore neural circuits underlying cognition and emotion. Her work integrates molecular, systems, and behavioral approaches to understand brain function and dysfunction. Recent publications highlight her focus on fear extinction, anxiety assessment tools, working memory enhancement via neuromodulation, and predictive models of PTSD . These studies reflect a strong trend toward translational neuroscience with implications for psychiatric and neurological disorders. Scientific Awards: VA Merit Award, VHA (2018) Integrity Award, AU Core Values, Augusta University (2017) Authentic Leadership for Women Academy, Augusta University (2017) VA Merit Award, VHA (2013) National Research Service Award, NIH (2003) Dr. Vazdarjanova has served on multiple graduate and faculty committees, including the Graduate Student Committee, MCG Faculty Affairs Committee, and Grievance Committee (where she served as Chair). She has been an ad hoc reviewer for the Society for Neuroscience. She teaches core medical and graduate courses such as Pharmacology & Therapeutics , Medical Physiology , Neuroscience I , and Neuropharmacology . While specific students are not listed, her role in seminars and tutorials suggests active mentorship. She is affiliated with the The Graduate School and participates in institutional research governance through the Partnership Council Committee on Research. There is no indication of part-time status, retirement, or emeritus designation.

Jordan TheriaultView profile

Assistant Professor

• Neuroscience
• Cognitive Science
• Neuroimaging
• +3 more

Jordan Theriault is an Assistant Professor at Northeastern University, affiliated with both the Biology and Psychology departments. His research focuses on understanding the brain as a self-regulating system, particularly exploring brain-based metabolic costs of information encoding and their implications for mental health and neuroimaging interpretation. He employs advanced neuroimaging technologies like 7 Tesla MRI and simultaneous PET/MR imaging to study brain metabolism and functional changes in critical regions like the brainstem and hypothalamus. Dr. Theriault’s theoretical work emphasizes the brain’s role in predicting sensory input and regulating bodily states, proposing that predictable environments enhance metabolic efficiency. This framework has implications for mental/physical health and social dynamics, such as conformity and social pressure. His lab, the Interdisciplinary Affective Sciences Laboratory, integrates neuroscience, psychology, and philosophy to address complex questions about emotion, morality, and interoceptive control. Key technical innovations include high-resolution imaging techniques and methodological critiques of brain-behavior relationships. His work bridges basic research with applied insights into human behavior, leveraging interdisciplinary approaches to advance understanding of neural systems and their societal relevance.

• Neuropharmacology
• Neuroendocrinology
• Sleep Research
• +3 more

Jessica A. Mong, PhD , is a Professor in the Department of Pharmacology & Physiology at the University of Maryland School of Medicine , where she also serves as Assistant Dean for Graduate & Post-Doctoral Studies and Director of Graduate Education for the Program in Neuroscience. Her research focuses on the neuroendocrine mechanisms underlying sex differences in sleep circuitry and the estrogenic modulation of sleep-wake cycles. Primary Appointment: Pharmacology & Physiology Administrative Title: Assistant Dean for Graduate & Post-Doctoral Studies Laboratory Director: Program in Neuroscience Research Interests: Dr. Mong's work investigates how ovarian steroids influence sleep-wake behavior through sexually differentiated neuroanatomical substrates. Key areas include: Mechanisms of estrogenic modulation in the median preoptic nucleus (MnPN) Developmental programming of sex differences in sleep sensitivity Translational studies using rodent and nonhuman primate models of menopause Functional significance of hormonal influences on sleep quality and recovery Scientific Trends: Her recent publications (2023-2025) emphasize: Role of KCNMA1 channelopathy in sleep regulation Adenosinergic signaling in MnPN Translational menopause models Estrogen's protective effects against noise-induced hearing loss Sex-dependent responses to kynurenine pathway challenges Awards & Appointments: NIH BIRCWH Scholar (Building Interdisciplinary Research Careers in Women's Health) Co-Chair, Society for Women’s Health Research Interdisciplinary Research Network on Sex-Differences in Sleep Health NIH/NHLBI R01 HL129138 grant recipient Education & Training: B.S., Biology, Gettysburg College (1987-1991) Ph.D., Neuropharmacology, University of Maryland Baltimore (1994-2000) NIH Postdoctoral Fellowship in Endocrinology, Rockefeller University (2000-2003)

Jenna Ann McHenryView profile

Assistant Professor

• Neuroscience
• Behavioral Neuroscience
• Neurobiology
• +4 more

Jenna Ann McHenry is an Assistant Professor of Psychology and Neuroscience and Neurobiology at Duke University, holding a primary appointment in the School of Medicine's Department of Neurobiology. As a Faculty Network Member of the Duke Institute for Brain Sciences, she leads the McHenry Lab focused on neural circuit mechanisms underlying social and motivated behaviors. Her educational background includes: Ph.D., Florida State University (2013) B.S., Florida State University (2007) Dr. McHenry's research defines fixed and flexible features of molecularly defined neural circuits controlling social and nonsocial motivated behaviors, with emphasis on hypothalamic subnuclei and connections to midbrain dopaminergic reward systems. Her lab employs optogenetics, in vivo deep-brain calcium imaging, viral/genetic targeting, and advanced behavioral analysis to investigate circuit processing in disorders including Autism Spectrum Disorders, Reproductive Mood Disorders, Eating Disorders, and Major Depression. Specializing in chronic deep-brain microscopy, her team tracks neural networks during awake behavioral states over time. Her publication record demonstrates consistent innovation in neural circuit analysis, with recurring themes of hormonal modulation of social reward circuits, state-dependent sensorimotor processing, and neural mechanisms of social homeostasis. Key contributions include identifying prepronociceptin neurons in arousal responses and elucidating how adolescent sleep shapes adult social preferences. Major recognitions include: NARSAD Young Investigator Award (2017) K99 Pathway to Independence Award (NIMH, 2017) Notable Nole Alumni Award (Florida State University, 2018) NRSA Postdoctoral Fellowship (NIMH, 2013) Dr. McHenry actively mentors graduate students and postdocs, with current lab openings advertised. Her research is supported by substantial grants including the Neurobiology Training Program (2024-2029), Establishing Neural Circuits for Social Homeostasis (2022-2027), and Illuminating Socially-Modulated Homeostatic Control Circuits (2022-2025). She teaches Behavioral Neuroendocrinology and research practicums across psychology and neuroscience programs. The McHenry Lab operates at the forefront of systems neuroscience, utilizing GSRB II facilities for deep-brain imaging and circuit manipulation. As part of the Duke Institute for Brain Sciences, the lab collaborates extensively on translational research bridging basic neural mechanisms with clinical applications in mental health disorders.

Katrina ChoeView profile

Assistant Professor

• Social Neuroscience
• Autism Spectrum Disorders
• Oxytocin Signaling
• +4 more

Katrina Choe serves as Assistant Professor in the Department of Psychology, Neuroscience & Behaviour at McMaster University and holds a Tier 2 Canada Research Chair in Neurobiology of Social Behaviour. Her research program investigates the multi-level neurobiological mechanisms underlying psychiatric disorders, with primary focus on autism spectrum disorders (ASD) and oxytocin signaling pathways. Her academic training includes: PhD in Neuroscience from McGill University (2013) Honours BSc in Zoology from University of Toronto (2002-2006) Postdoctoral Fellowship at UCLA (2013-2020) Dr. Choe's research employs an integrative approach spanning molecular, cellular, circuit, and network levels to examine how ASD-associated gene mutations disrupt social behavior. Current work centers on oxytocin signaling mechanisms in ASD, convergent neurobiological pathways across psychiatric disorders, and the role of glial cells in neural circuit function. Her lab utilizes advanced techniques including optogenetic fMRI, single-cell RNA sequencing, and multi-level behavioral assays in genetic mouse models. Analysis of her 15 most recent publications reveals a clear research trajectory: early work (2015-2020) established foundational knowledge in vasopressin neuron regulation and salt homeostasis, while recent publications (2022-2025) demonstrate a focused shift toward ASD mechanisms, oxytocin signaling, and social circuit dysfunction using the Cntnap2 knockout model. This evolution reflects her transition from postdoctoral training to independent research leadership. Her scientific recognition includes: Tier 2 Canada Research Chair in Neurobiology of Social Behaviour (2022) NIMH K99/R00 Award CIHR Postdoctoral Fellowship Dr. Choe actively mentors six graduate students across PhD and MSc programs while leading a dynamic research team comprising postdoctoral fellows, laboratory technicians, and undergraduate researchers. Her program receives substantial support from major grants including a 5-year CIHR Project Grant and NSERC Discovery Grant focused on 'The role of CASPR2 in central oxytocin system development.' The Choe Lab maintains active collaborations with leading neuroscience groups including the Bourque, Prager-Khoutorsky, and Cunningham labs, as evidenced by participation in the 4th 1000 Islands/Gananoque Meeting on Hypothalamic Mechanisms. Her laboratory, established in 2020, operates as a multidisciplinary hub utilizing molecular biology (qPCR, RNA-seq), advanced imaging (lightsheet, confocal), electrophysiology (in vitro and in vivo), and behavioral neuroscience approaches to investigate social behavior mechanisms. Current projects examine microglia-astrocyte-neuron interactions in social circuit function and the therapeutic potential of oxytocin for ASD-related social deficits.

Antonio Verdejo-GarciaView profile

Professor

• Addiction
• Obesity
• Substance Abuse
• +5 more

Antonio Verdejo-Garcia is a Professor (Research) in the School of Psychological Sciences and the Turner Institute for Brain and Mental Health at Monash University. He holds an NHMRC Leadership Fellowship and serves as Co-Chair of the Neuroscience Interest Group at the International Society of Addiction Medicine. He has an Adjunct Honorary Appointment at Turning Point (Eastern Health). His academic journey includes a PhD from the University of Granada (2006) and postdoctoral training at Johns Hopkins University, University of Cambridge, and Institut Hospital del Mar d'Investigacions Mediques. Before joining Monash in 2012, he held roles as Lecturer, Senior Lecturer, and Associate Professor at the University of Granada. Research interests center on cognitive and neural mechanisms of executive control, decision-making, and their implications for addiction, compulsive eating, and obesity. He has authored over 290 peer-reviewed articles, edited a book on Cognition & Addiction, and secured continuous national/international research funding. His work has garnered over 17,000 citations. He serves on editorial boards for journals like Addiction , PLoS One , and Current Addiction Reports . Key projects include the AAT-APP Trial for alcohol use disorder, decoding drivers of food choices for obesity management, and neurocircuitry studies in addiction. Recent articles (2023–2025) focus on impulsivity, telehealth interventions for eating disorders, and neuropharmacological comparisons between MDMA and methamphetamine users. Scientific achievements include NHMRC Leadership Fellowship and contributions to clinical translation of cognitive rehabilitation. He advises on grants and mentors students in addiction neuroscience. Current projects involve psilocybin treatment for anorexia nervosa and cortical control of feeding circuits.

Yoon Seok KimView profile

Research Fellow

• Optogenetics
• Structural Biology
• Neuroscience
• +3 more

Dr. Yoon Seok Kim is a Postdoctoral Fellow at Stanford University’s Department of Bioengineering, focusing on structural and mechanistic studies of light-gated ion channels. He earned his Ph.D. in Bioengineering at Stanford, mentored by Drs. Karl Deisseroth and Brian Kobilka, with research centered on ion channel selectivity and optogenetic applications. Education: Ph.D. in Bioengineering, Stanford University Dr. Kim’s research spans Optogenetics , Structural Biology , and Neuroscience , particularly the molecular mechanisms of ion channels in neural and glioma contexts. His work includes structural analysis of potassium-selective channelrhodopsins and synaptic mechanisms in neurodegenerative diseases. Recent publications highlight interdisciplinary trends, merging Neuroscience , Molecular Biology , and Bioengineering , with subfields like diffuse midline gliomas , dopamine neuron resilience , and machine learning in protein engineering . His studies often integrate advanced imaging and optogenetic tools.

Juan SongView profile

Professor

• Adult Neurogenesis
• Neuroscience
• Neurodegenerative Diseases
• +5 more

Dr. Juan Song is a **Professor** and **Jeffrey Houpt Distinguished Investigator** in the Department of Pharmacology at the University of North Carolina (UNC) School of Medicine. Her research focuses on adult neurogenesis mechanisms, neural circuit regulation, and applications to neuropsychiatric disorders and neurodegenerative diseases such as Alzheimer’s. She leads the Song Lab, which employs advanced techniques like optogenetics, electrophysiology, and genetic models. Dr. Song earned her Ph.D. from UC Berkeley and completed postdoctoral training at Johns Hopkins University before establishing her independent lab at UNC in 2013. She was promoted to Full Professor in 2023. **Education**: Ph.D. in Neuroscience, University of California, Berkeley (2007); Postdoctoral Fellowship at Johns Hopkins University (2007–2013). **Research Interests**: Circuit mechanisms regulating adult neurogenesis, hippocampal neurogenesis and memory, Alzheimer’s disease modeling, and translational therapies. Her lab explores how neural circuits influence stem cell activation and newborn neuron integration, with implications for schizophrenia, autism, stroke, and Alzheimer’s. **Publications**: Over 50 peer-reviewed articles, including high-impact work in *Cell Stem Cell*, *Nature Neuroscience*, and *Neuron*. Recent studies focus on cholinergic circuits in neurogenesis, hypothalamic modulation of cognitive function, and G9a inhibitors for Alzheimer’s. **Advising & Grants**: Mentors postdocs, graduate students, and undergraduates. Active in training programs like BBSP and MSTP. Her lab collaborates on projects involving neural stem cell regulation and circuit-based therapies. **Lab & Affiliations**: Song Lab (UNC Neuroscience Center) develops innovative tools like transdermal drug delivery systems and employs cutting-edge imaging techniques. Collaborates with institutions globally on neurodegenerative disease research.

Reilly T. EnosView profile

Assistant Professor

• Obesity
• Metabolic Disease
• Sex Differences in Metabolism
• +9 more

Reilly T. Enos, PhD, is an Assistant Professor in the Department of Pathology, Microbiology & Immunology at the University of South Carolina School of Medicine. His research focuses on the molecular mechanisms of sex differences in obesity, particularly metabolic and inflammatory processes influenced by sex steroids. The Enos Lab employs rodent models and advanced metabolic phenotyping to investigate menopause-related metabolic dysfunction and complementary therapies. PhD, Exercise Science (Applied Physiology), University of South Carolina, 2013 Post-Doctoral, Complementary and Alternative Medicine in Cancer and Obesity, University of South Carolina School of Medicine, 2017 MS, Exercise Physiology, Baylor University, 2009 BS, Dietetics, University of Northern Colorado, 2010 BA, Spanish & Physical Education, College of Wooster, 2007 Dr. Enos’s research spans immunometabolism, obesity, cancer cachexia, and gut microbiota. His work explores how dietary components (e.g., quercetin, emodin), hormonal status (especially estrogen), and immune modulation (e.g., miR-155, macrophages) influence metabolic and oncological outcomes. He investigates sex-specific responses to high-fat diets, inflammation, and therapeutic interventions using transgenic and diet-induced mouse models. His recent publications highlight trends in metabolic physiology, inflammation, and cancer, often examining the interplay between adipose tissue, immune cells, and hormonal regulation. Key themes include the impact of vivarium conditions on reproducibility, the role of microRNAs in tumorigenesis, and the safety and efficacy of natural compounds. Dr. Enos has not been awarded any listed scientific prizes or fellowships in the provided texts. He advises a research team focused on metabolic and inflammatory disease models, frequently collaborating with researchers such as Erin A. Murphy and Kandy T. Velázquez. His lab receives funding for studies on obesity, cancer, and complementary medicine, though specific grants are not detailed. The lab is equipped for metabolic phenotyping and rodent model studies. The Enos Lab is dedicated to understanding sex-specific metabolic regulation and developing targeted therapies for obesity and cancer-related metabolic disorders, with a focus on translational relevance and experimental rigor.